Northern Trust’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
Northern Trust's BBH Position: Q3 2026 in Review
Northern Trust reduced its VanEck Biotech ETF (BBH) stake by 15% in Q3 2026, selling an estimated $49.1K and leaving 1,257 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #3775.
Northern Trust first reported a position in BBH in Q3 2020 and has held it in 11 quarters since. The position peaked at $699K in Q2 2021. 123 funds tracked by Wall St. Rank hold BBH as of Q3 2026.
- Northern Trust held 1,257 shares of VanEck Biotech ETF worth $307K as of Q3 2026.
- Northern Trust sold 220 VanEck Biotech ETF shares in Q3 2026, an estimated $49.1K.
- VanEck Biotech ETF made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3775 holding.
- Northern Trust first reported a position in VanEck Biotech ETF in Q3 2020 and has held it in 11 quarters since.
- Northern Trust's VanEck Biotech ETF position peaked at $699K in Q2 2021.
- 123 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.